On December 17, the European Union published MRL amendment Commission Regulation (EU) No 1317/2013 in the EU Official Journal. This regulation revises MRLs for 2,4-D, beflubutamid, cyclanilide, diniconazole, florasulam, metolachlor and S-metolachlor, and milbemectin.
MRL revisions were made to address new and changed uses. This amendment will enter into force July 6, 2014.
Relevant changes will appear in www.mrldatabase.com after the regulation is in effect.